Comparative efficacy and safety of Chinese medicine injections as an adjunctive therapy for cervical cancer in Chinese patients: a network meta-analysis

Comparative efficacy and safety of Chinese medicine injections as an adjunctive therapy for cervical cancer in Chinese patients: a network meta-analysis

Context Chinese medicine injections (CMIs) are widely used as adjuvant therapy for cervical cancer in China. However, the effectiveness of different types of CMIs remains uncertain.Objective To assess the effectiveness and safety of CMIs when used in conjunction with radiotherapy (RT) or concurrent...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fei Ma, Qun Wang, Di Zhang, Zihong Wang, Hui Xie, Xianghong Liu, Hongxing Zhang, Haiyan Song, Shiguang Sun
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Pharmaceutical Biology
Subjects:	Chinese medicine injections (CMIs) Radiotherapy (RT) concurrent chemoradiotherapy (CCRT) efficacy safety network meta-analysis
Online Access:	https://www.tandfonline.com/doi/10.1080/13880209.2024.2312217
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Quality of life in patients with pan-cancer undergoing concurrent chemoradiotherapy: a bibliometric analysis (1995-2024)
by: Ao Shen, et al.
Published: (2025-08-01)

Harnessing unsupervised machine learning with [18F]FDG PET/CT to develop a composite model for predicting overall survival in cervical cancer patients undergoing concurrent chemoradiotherapy
by: Jinyu Shi, et al.
Published: (2025-05-01)

Efficacies of radiotherapy in rectal cancer patients treated with total mesorectal excision or other types of surgery: an updated meta-analysis
by: Wenshu Wang, et al.
Published: (2025-05-01)

The clinical outcomes of induction chemotherapy followed by radiotherapy vs. chemoradiotherapy in locally advanced hypopharyngeal squamous cell carcinoma: A retrospective study
by: Ke Jiang, et al.
Published: (2024-10-01)

Concurrent vs. sequential chemoradiotherapy: a survival boost for lung cancer patients
by: Jinbiao Xu, et al.
Published: (2025-05-01)

Comment on: Concurrent chemoradiotherapy versus radiotherapy alone in postoperative high-risk adenoid cystic carcinoma of the head and neck: A propensity score-matched analysis
by: Erkan Topkan, et al.
Published: (2025-07-01)

Longitudinal dynamic MRI radiomic models for early prediction of prognosis in locally advanced cervical cancer treated with concurrent chemoradiotherapy
by: Chang Cai, et al.
Published: (2024-12-01)

Prognostic analysis of nimotuzumab combined with concurrent chemoradiotherapy for locally advanced cervical cancer: a multicenter real-world study
by: Jiwei Li, et al.
Published: (2025-05-01)

The impairment of induction chemotherapy for stage II nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy with or without concurrent chemotherapy: A propensity score‐matched analysis
by: YuLin Lai, et al.
Published: (2023-02-01)

Effect of primary tumor volume on survival of concurrent chemoradiotherapy in stage IV non‐small cell lung cancer
by: Xiaxia Chen, et al.
Published: (2024-09-01)

Potential biomarkers develop for predicting the prognosis of patients with esophageal squamous cell carcinoma after optimized chemoradiotherapy using serum metabolomics
by: Jie Yang, et al.
Published: (2025-03-01)

A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer
by: Arunima Gupta, et al.
Published: (2014-01-01)

Effects of thoracic radiotherapy timing and duration on progression‐free survival in limited‐stage small cell lung cancer
by: Shen Zhao, et al.
Published: (2018-09-01)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
by: Mao‐Chih Hsieh, et al.
Published: (2018-06-01)

MRI radiomics and nutritional-inflammatory biomarkers: a powerful combination for predicting progression-free survival in cervical cancer patients undergoing concurrent chemoradiotherapy
by: Qi Yan, et al.
Published: (2024-10-01)

Prediction of outcomes after chemoradiotherapy for cervical cancer by neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio
by: Jing Yu, et al.
Published: (2024-12-01)

Consolidation immunotherapy following concurrent chemoradiotherapy in a patient with sinonasal NUT carcinoma: a case report
by: Xiaotao Geng, et al.
Published: (2024-12-01)

A phase I study of S-1 and cisplatin with concurrent hypofractionated carbon-ion radiotherapy for patients with stage III non-small cell lung cancer
by: Yosuke Miura, et al.
Published: (2025-08-01)

Development and validation of a prognostic nomogram incorporating neutrophil-to-albumin ratio for predicting overall survival in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy
by: Xin Hua, et al.
Published: (2025-01-01)

Cholesterol-to-lymphocyte ratio (CLR)-based nomogram as a prognostic tool in nasopharyngeal carcinoma: a large-scale long-term retrospective study
by: Jing Yuan, et al.
Published: (2025-07-01)

Effect of concurrent chemoradiation with cisplatin versus concurrent chemoradiation with carboplatin in locally advanced carcinoma cervix: A quasi-experimental study
by: Syed Md. Asadul Hoque, et al.
Published: (2025-05-01)

Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy
by: Fiorella Di Pastena, et al.
Published: (2024-11-01)

A Phase II Clinical Trial of Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced High-Grade Thymic Tumors
by: Ning Xu, MD, et al.
Published: (2025-06-01)

Comparison of oncological outcomes and complication rate between radical hysterectomy and concurrent chemoradiotherapy in stage IIICr cervical cancer without parametrial invasion
by: Hee Yeun Yoon, et al.
Published: (2025-04-01)

Integrating pan-immune-inflammation value into personalized survival prediction of nasopharyngeal carcinoma: a large-scale long-term retrospective study
by: Wen-Chao Li, et al.
Published: (2025-07-01)

Sequential therapy (triple drug-based induction chemotherapy followed by concurrent chemoradiotherapy) in locally advanced inoperable head and neck cancer patients - Single institute experience
by: Naresh Somani, et al.
Published: (2011-01-01)

Tislelizumab and GP regimen neoadjuvant therapy followed by concurrent chemoradiotherapy with nimotuzumab in patients with stage IVA nasopharyngeal carcinoma: a retrospective study
by: Mingfen Lai, et al.
Published: (2025-06-01)

Prognostic implications of tumor volume reduction during radiotherapy in locally advanced cervical cancer: a risk-stratified analysis
by: Canyang Lin, et al.
Published: (2025-03-01)

S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective study
by: Xin Wang, et al.
Published: (2024-12-01)

A comparative analysis of survival outcomes and adverse effects between preoperative brachytherapy with radical surgery and concurrent chemoradiotherapy in patients with locally advanced cervical cancer
by: Yuna Niu, et al.
Published: (2025-02-01)

Current principles for the planning and performance of radiotherapy in the conservative treatment of locally advanced cancer of the cervix uteri
by: Yu. M. Kreynina, et al.
Published: (2014-07-01)

Efficacy and safety of puerarin injection as an adjunctive therapy for chronic heart failure: a systematic review and meta-analysis
by: Hesong Fan, et al.
Published: (2025-04-01)

Concurrent chemoradiotherapy with S-1 versus platinum in the treatment of locoregionally advanced nasopharyngeal carcinoma: a multicenter, retrospective, propensity score-matched analysis
by: Chenbin Bian, et al.
Published: (2024-11-01)

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
by: Dalia Elsayed, et al.
Published: (2023-04-01)

Nomogram based on the advanced lung cancer inflammation index and other relevant clinical factors for patients with cervical squamous cell carcinoma undergoing concurrent chemoradiotherapy
by: Xiao-Chun Wang, et al.
Published: (2025-07-01)

Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II clinical trial
by: Ke Zhang, et al.
Published: (2025-02-01)

Chinese herbal injections in combination with radiotherapy for advanced pancreatic cancer: A systematic review and network meta-analysis
by: Yun-Ru Chen, et al.
Published: (2023-12-01)

Ten-year survival outcomes of concurrent chemoradiotherapy with or without adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma in the IMRT era: A retrospective cohort study stratified by high- and low-risk profiles
by: Wang-Jian Li, et al.
Published: (2025-09-01)

Immunotherapy concurrently administered with chemoradiotherapy in limited-stage small-cell lung cancer
by: Liuhua Long, et al.
Published: (2025-07-01)

Single-cell RNA sequencing analysis reveals a lack of CXCL13+ T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy
by: Xia Li, et al.
Published: (2025-06-01)